Organon
A global healthcare company with a portfolio of therapies and products in women’s health.
Launch date
Employees
Market cap
$5.3b
Enterprise valuation
$13.2b (Public information from Sep 2024)
Share price
$20.18 OGN
Jersey City New Jersey (HQ)
Financials
Estimates*
| USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 7.8b | 8.1b | 6.3b | 6.2b | 6.3b | 6.4b | 6.4b |
| % growth | (20 %) | 4 % | (22 %) | (2 %) | 1 % | 2 % | 1 % |
| EBITDA | 4.2b | 3.0b | 1.8b | 1.7b | 1.5b | - | - |
| % EBITDA margin | 54 % | 37 % | 29 % | 27 % | 25 % | - | - |
| Profit | 3.2b | 2.2b | 1.4b | 917m | 1.0b | - | - |
| % profit margin | 41 % | 27 % | 21 % | 15 % | 16 % | - | - |
| R&D budget | 220m | 304m | 443m | 471m | 528m | - | - |
| R&D % of revenue | 3 % | 4 % | 7 % | 8 % | 8 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
* | N/A | $1.0b | Post IPO Debt |
| Total Funding | - | ||
Related Content
Recent News about Organon
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Organon
Edit
ACQUISITION by Organon Sep 2024
ACQUISITION by Organon Nov 2021
